Independence



DTB's aim is to provide informed and unbiased information on medical conditions, medicines and other treatments to enable people to make informed choices.

True to this objective, DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship.

All contributors are asked to declare whether they have any interests or relationships they think might influence their comments. These potential conflicts are taken into account during the editorial process.

In addition, the extensive peer-review process exposes potential conflicts of interest. All comments must be supported by appropriate evidence.

About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 2008 BMJ Publishing Group Ltd.